Percutaneous Guidewire Placement Syringe 50505
by Dlp, Inc.
510(k) K855089
Active
Valid until
No expiry
FDA recalls
None foundDocuments
Trust
Unverified
Regulatory status
| Region | Authorization | Number | Date | Status |
|---|---|---|---|---|
| United States | FDA 510(k)SESE | NumberK855089 | Date18 Feb 1986 | StatusActive |
Recalls
No FDA recalls found in the data synced 22 Oct 2026.
Coverage
- Active
- Expiring
- Withdrawn
- Listed
- Not covered
United States — FDA 510(k) Active
Specification
- 510(k) Number
- FDA Product Code
- DQX
- Device Class
- Class II
- Regulation
- 21 CFR Part 870.1330
- Advisory Committee
- Cardiovascular
- FDA Decision
- SESE Substantially Equivalent
Overview
AI-generated summary, 19 Sep 2026
The Percutaneous Guidewire Placement Syringe 50505 is a Class II medical device classified under the category of Traditional Wire, Guide, Catheter (DQX). It is designed to assist in the placement of guidewires through percutaneous catheters, facilitating navigation within blood vessels during interventional procedures.
This syringe is intended for single-use in clinical settings and has received FDA 510(k) clearance under the Cardiovascular advisory committee. The device is supplied sterile and is regulated as a substantially equivalent product to a predicate device, with clearance granted on February 18, 1986. No additional regulatory markings or conditions are specified.
Other devices from Dlp, Inc.
Questions
AI-generated answers, 19 Sep 2026
What is the Percutaneous Guidewire Placement Syringe 50505 primarily used for in medical procedures?
The Percutaneous Guidewire Placement Syringe 50505 is designed to assist in placing guidewires through percutaneous catheters during interventional procedures. It helps navigate guidewires within blood vessels, ensuring precise and controlled placement for procedures like angioplasty or stenting.
Is this syringe intended for reuse in clinical settings, or is it meant for single-use only?
The device is explicitly labeled for single-use in clinical settings. This ensures patient safety and sterility, as it is supplied sterile and not intended to be reused after one procedure.
How is the regulatory status of this syringe determined, and which advisory committee was involved?
The Percutaneous Guidewire Placement Syringe 50505 received FDA 510(k) clearance under the Cardiovascular advisory committee (CV). It was classified as *substantially equivalent* to a predicate device, meaning its safety and effectiveness were deemed comparable to an already-approved product in the same category (product code DQX).
What should clinicians consider when storing this syringe before use?
Since the syringe is supplied sterile, it should be stored in a clean, dry environment away from direct sunlight or extreme temperatures. The packaging should remain intact until immediate use to maintain sterility and prevent contamination.